NasdaqGM:ANIPPharmaceuticals
ANI Pharmaceuticals (ANIP): Gauging Valuation After Bold 2025 Revenue Forecasts Propel Shares
ANI Pharmaceuticals (ANIP) has just turned heads with its latest announcement, projecting 2025 revenues in the range of $818 million to $843 million. That’s a jump of 33% to 37% over last year, a confident call from management that’s tough to ignore if you’re weighing your next move. This new guidance seems to have struck a chord with the market, and it’s no surprise; bold forecasts often get investors reassessing what the company might be worth.
The positive momentum was already in motion...